
Cataract
Latest News
Latest Videos

Podcasts
CME Content
More News

According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity.

Revisyon is described as a device-led therapy that applies specific wavelengths of low-level LED light to the crystalline lens through a non-invasive, in-clinic procedure.

The acquisition focuses on LayerBio's OcuRing-K technology, with plans to initiate the next clinical trial.

Carlos Chacon, OD, MSc, FIACLE, cited economic and geographic barriers and nonstandardized education as the major barriers keeping patients from adequate eye care in Latin America.

The novel intraocular lens works to restore dynamic range of vision following cataract surgery.

The 3200 square-foot unit offers diagnostics, cataract surgery, YAG laser capsulotomy, and post op care.

The LuxLife full range of vision IOL is available in a range of cylinders spanning from +0.75D to +6.00D.

The surgery isn't over until the healing is don

Of participants surveyed, 36% reported a fear of cataract surgery, with more than half of those specifically feared it would lead to vision loss.

The lens has been introduced to select practices across the US, with broad commercial availability planned for in May.

The grant will allow the research team to determine the novel mechanisms that convert immature eye lens precursors cells into functional transparent cells.

Cationic emulsion drops are characterized by their ability to retain cyclosporine A on the ocular surface.

Persistent ocular surface dysfunction after cataract surgery impacts patient satisfaction despite 20/20 vision, with pre-op screening and tailored care being key components.

A total of 150 placements are for aspiring optometrists to shadow SpaMedica’s clinical teams and in-house optometrists as they treat patients.

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.

The primary endpoint of the 4-month study was the proportion of patients with clinically significant improvements in the contrast sensitivity.

Study investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with one case of traumatic cataract.

Removing drops improves adherence and comfort for most patients.

Adam Ramsey, OD, focused on managing patient expectations and addressing unmet outcomes during a featured symposium on key advances in cataract surgery at EyeCon 2023. He also previewed his upcoming lecture on utilizing virtual assistants to revolutionize the patient experience in eye care.

Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, FAAO, recap the diverse topics at EyeCon 2023, emphasizing the collaborative spirit between optometrists and ophthalmologists in addressing issues such as myopia management, diabetic eye conditions, cataract surgery, and patient referrals.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.

The financing will help advance the company’s novel treatment system for glaucoma and other chronic ophthalmic diseases.

Annual meeting places spotlight on newest clinical techniques, industry trends.

































